nach oben

Erschienen in:

12.02.2019 | Original Article

Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile

verfasst von: Christian Johana Baños-Hernández, José Eduardo Navarro-Zarza, Richard Bucala, Jorge Hernández-Bello, Isela Parra-Rojas, María Guadalupe Ramírez-Dueñas, Samuel García-Arellano, Luis Alexis Hernández-Palma, Andrea Carolina Machado-Sulbarán, José Francisco Muñoz-Valle

Erschienen in: Clinical Rheumatology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Systemic sclerosis (SSc) is a complex autoimmune disease, characterized by microvascular lesions, autoimmunity, and fibrosis. It is suggested that MIF participates in the amplification of the proinflammatory process in SSc; moreover, the promoter polymorphisms − 794 CATT_5–8 (rs5844572) and − 173G>C (rs755622) in the MIF gene have been associated with an increase in MIF serum levels in several autoimmune diseases. The aim of this study was to analyze the relationship of the − 794 CATT_5–8 and − 173G>C MIF polymorphisms with mRNA expression, MIF serum levels, and the Th1/Th2/Th17 cytokine profile in SSc.

Materials and methods

A case-control study was carried out that included 50 patients with SSc and 100 control subjects (CS). Both polymorphisms were genotyped by PCR and PCR-RFLP. MIF levels were measured by ELISA kit. The cytokine profile and the MIF mRNA expression were quantified by BioPlex MagPix system and real-time PCR, respectively.

Results

An association between the − 794 CATT₇ and − 173*C MIF alleles and the 7C haplotype with SSc susceptibility was found (p < 0.05). Also, the 7C haplotype was associated with increased MIF mRNA expression (p = 0.03) in SSc. In addition, an increase of IL-1β and IL-6 serum levels in SSc patients was found as well as a positive correlation between MIF serum levels and Th1 and Th17 cytokine profiles.

Conclusion

The MIF 7C haplotype is a susceptibility marker for SSc in the southern Mexican population and is associated with MIF mRNA expression. Moreover, there is a positive correlation between MIF serum levels and Th1 and Th17 inflammatory response in SSc.

Barsotti S, Stagnaro C, d'Ascanio A et al (2016) One year in review 2016: systemic sclerosis. Clin Exp Rheumatol 34 Suppl 100(5):3–13

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747CrossRefPubMedPubMedCentral

Katsumoto TR, Whitfield ML, Connolly MK (2011) The pathogenesis of systemic sclerosis. Annu Rev Pathol 6:509–537CrossRefPubMed

Stern EP, Denton CP (2015) The pathogenesis of systemic sclerosis. Rheum Dis Clin N Am 41(3):367–382CrossRef

Selvi E, Tripodi SA, Catenaccio M, Lorenzini S, Chindamo D, Manganelli S, Romagnoli R, Ietta F, Paulesu L, Miracco C, Cintorino M, Marcolongo R (2003) Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Ann Rheum Dis 62(5):460–464CrossRefPubMedPubMedCentral

Ramos PS, Silver RM, Feghali-Bostwick CA (2015) Genetics of systemic sclerosis: recent advances. Curr Opin Rheumatol 27(6):521–529CrossRefPubMedPubMedCentral

Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3(10):791–800CrossRefPubMedPubMedCentral

Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 99(1):345–350CrossRefPubMed

Kim JY, Kwok SK, Hur KH, Kim HJ, Kim NS, Yoo SA, Kim WU, Cho CS (2008) Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis. Clin Exp Immunol 152(2):328–335CrossRefPubMedPubMedCentral

10.

Llamas-Covarrubias MA, Valle Y, Bucala R, Navarro-Hernández RE, Palafox-Sánchez CA, Padilla-Gutiérrez JR, Parra-Rojas I, Bernard-Medina AG, Reyes-Castillo Z, Muñoz-Valle JF (2013) Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine 61(3):759–765CrossRefPubMedPubMedCentral

11.

Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U et al (2014) Macrophage migration inhibitory factor (MIF) promoter polymorphisms (−794 CATT5-8 and −173 G>C): association with MIF and TNFalpha in psoriatic arthritis. Int J Clin Exp Med 7(9):2605–2614PubMedPubMedCentral

12.

De la Cruz-Mosso U, Bucala R, Palafox-Sanchez CA et al (2014) Macrophage migration inhibitory factor: association of −794 CATT5-8 and −173 G>C polymorphisms with TNF-alpha in systemic lupus erythematosus. Hum Immunol 75(5):433–439CrossRefPubMedPubMedCentral

13.

Castaneda-Moreno VA, De la Cruz-Mosso U, Torres-Carrillo N et al (2018) MIF functional polymorphisms (−794 CATT5-8 and −173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population. J Neuroimmunol 320:117–124CrossRefPubMed

14.

Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3(3):170–176CrossRefPubMed

15.

Yao J, Leng L, Sauler M, Fu W, Zheng J, Zhang Y, du X, Yu X, Lee P, Bucala R (2016) Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus. J Clin Invest 126(2):732–744CrossRefPubMedPubMedCentral

16.

Gregersen PK, Bucala R (2003) Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48(5):1171–1176CrossRefPubMed

17.

Wu SP, Leng L, Feng Z, Liu N, Zhao H, McDonald C, Lee A, Arnett FC, Gregersen PK, Mayes MD, Bucala R (2006) Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum 54(11):3661–3669CrossRefPubMed

18.

Bossini-Castillo L, Simeon CP, Beretta L, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, Camps MT, Rodríguez-Rodríguez L, Rodríguez-Carballeira M, García-Hernández FJ, López-Longo FJ, Hernández-Hernández V, Sáez-Comet L, Egurbide MV, Hesselstrand R, Nordin A, Hoffmann-Vold AM, Vanthuyne M, Smith V, de Langhe E, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Voskuyl AE, Schuerwegh AJ, Lunardi C, Airó P, Scorza R, Shiels P, van Laar JM, Fonseca C, Denton C, Herrick A, Worthington J, Koeleman BP, Rueda B, Radstake TRDJ, Martin J (2011) Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Rheumatology 50(11):1976–1981CrossRefPubMed

19.

Becker H, Willeke P, Schotte H, Domschke W, Gaubitz M (2008) Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis. Clin Rheumatol 27(10):1307–1311CrossRefPubMed

20.

Ningyan G, Xu Y, Hongfei S, Jingjing C, Min C (2015) The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production. PLoS One 10(3):e0122482CrossRefPubMedPubMedCentral

21.

Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRefPubMedPubMedCentral

22.

Radstake TR, Sweep FC, Welsing P et al (2005) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 52(10):3020–3029CrossRefPubMed

23.

Makhija R, Kingsnorth A, Demaine A (2007) Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. JOP 8(3):289–295PubMed

24.

Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156–159CrossRefPubMed

25.

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408CrossRefPubMed

26.

Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15(2):97–98CrossRefPubMed

27.

Hong EP, Park JW (2012) Sample size and statistical power calculation in genetic association studies. Genomics Inform 10(2):117–122CrossRefPubMedPubMedCentral

28.

Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*power 3.1: tests for correlation and regression analyses. Behav Res Methods 41(4):1149–1160CrossRefPubMed

29.

Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1):149–150CrossRefPubMed

30.

Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, Assassi S, Ying J, Tan FK, Arnett FC, Reveille JD, Guerra S, Teruel M, Carmona FD, Gregersen PK, Lee AT, López-Isac E, Ochoa E, Carreira P, Simeón CP, Castellví I, González-Gay MÁ, Zhernakova A, Padyukov L, Alarcón-Riquelme M, Wijmenga C, Brown M, Beretta L, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Distler JHW, Voskuyl AE, Schuerwegh AJ, Hesselstrand R, Nordin A, Airó P, Lunardi C, Shiels P, van Laar JM, Herrick A, Worthington J, Denton C, Wigley FM, Hummers LK, Varga J, Hinchcliff ME, Baron M, Hudson M, Pope JE, Furst DE, Khanna D, Phillips K, Schiopu E, Segal BM, Molitor JA, Silver RM, Steen VD, Simms RW, Lafyatis RA, Fessler BJ, Frech TM, AlKassab F, Docherty P, Kaminska E, Khalidi N, Jones HN, Markland J, Robinson D, Broen J, Radstake TRDJ, Fonseca C, Koeleman BP, Martin J, Ortego-Centeno N, Ríos R, Callejas JL, Navarrete N, García Portales R, Camps MT, Fernández-Nebro A, González-Escribano MF, Sánchez-Román J, García-Hernández FJ, Castillo MJ, Aguirre MÁ, Gómez-Gracia I, Fernández-Gutiérrez B, Rodríguez-Rodríguez L, Vicente E, Andreu JL, Fernández de Castro M, García de la Peña P, López-Longo FJ, Martínez L, Fonollosa V, Espinosa G, Tolosa C, Pros A, Rodríguez Carballeira M, Narváez FJ, Rubio Rivas M, Ortiz Santamaría V, Díaz B, Trapiella L, Freire MC, Sousa A, Egurbide MV, Fanlo Mateo P, Sáez-Comet L, Díaz F, Hernández V, Beltrán E, Román-Ivorra JA, Grau E, Alegre Sancho JJ, Blanco García FJ, Oreiro N, Fernández Sueiro L (2014) Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet 94(1):47–61CrossRefPubMedPubMedCentral

31.

Sreih A, Ezzeddine R, Leng L, LaChance A, Yu G, Mizue Y, Subrahmanyan L, Pons-Estel BA, Abelson AK, Gunnarsson I, Svenungsson E, Cavett J, Glenn S, Zhang L, Montgomery R, Perl A, Salmon J, Alarcón-Riquelme ME, Harley JB, Bucala R (2011) Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum 63(12):3942–3951CrossRefPubMedPubMedCentral

32.

Norton BJ, Strube MJ (2001) Understanding statistical power. J Orthop Sports Phys Ther 31(6):307–315CrossRefPubMed

33.

Button KS, Ioannidis JP, Mokrysz C et al (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14(5):365–376CrossRefPubMed

34.

Bryc K, Durand EY, Macpherson JM, Reich D, Mountain JL (2015) The genetic ancestry of African Americans, Latinos, and European Americans across the United States. Am J Hum Genet 96(1):37–53CrossRefPubMedPubMedCentral

35.

Roy-Gagnon MH, Moreau C, Bherer C, St-Onge P, Sinnett D, Laprise C, Vézina H, Labuda D (2011) Genomic and genealogical investigation of the French Canadian founder population structure. Hum Genet 129(5):521–531CrossRefPubMed

36.

Martinez-Cortes G, Salazar-Flores J, Fernandez-Rodriguez LG et al (2012) Admixture and population structure in Mexican-mestizos based on paternal lineages. J Hum Genet 57(9):568–574CrossRefPubMed

37.

Corallo C, Paulesu L, Cutolo M, Ietta F, Carotenuto C, Mannelli C, Romagnoli R, Nuti R, Giordano N (2015) Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis. Clin Exp Rheumatol 33(4 Suppl 91):S98–S105PubMed

38.

Karres I, Kremer JP, Dietl I et al (1998) Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am J Phys 274(4 Pt 2):R1058–R1064

39.

Church TS, Willis MS, Priest EL, LaMonte MJ, Earnest CP, Wilkinson WJ, Wilson DA, Giroir BP (2005) Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes 29(6):675–681CrossRef

40.

Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860–867CrossRefPubMed

41.

Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796–1808CrossRefPubMedPubMedCentral

42.

Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821–1830CrossRefPubMedPubMedCentral

43.

Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A (2004) Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89(10):5043–5047CrossRefPubMed

44.

Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377(6544):68–71CrossRefPubMed

45.

Kamchybekov U, Figulla HR, Gerdes N, Jung C (2012) Macrophage migration inhibitory factor is elevated in obese adolescents. Arch Physiol Biochem 118(4):204–209CrossRefPubMed

46.

Llamas-Covarrubias MA, Valle Y, Navarro-Hernandez RE et al (2012) Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course. Rheumatol Int 32(8):2307–2311CrossRefPubMed

47.

Roger T, David J, Glauser MP, Calandra T (2001) MIF regulates innate immune responses through modulation of toll-like receptor 4. Nature 414(6866):920–924CrossRefPubMed

48.

Hong Z, Jiang Z, Liangxi W, Guofu D, Ping L, Yongling L, Wendong P, Minghai W (2004) Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release. Int Immunopharmacol 4(2):223–234CrossRefPubMed

49.

Meloni F, Solari N, Cavagna L et al (2009) Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol 27(5):765–772PubMed

50.

Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, Muroi E, Hara T, Ogawa F, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S (2010) Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 185(4):2502–2515CrossRefPubMed

51.

Rodriguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J et al (2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32(9):2653–2660CrossRefPubMed

52.

O'Reilly S, Hugle T, van Laar JM (2012) T cells in systemic sclerosis: a reappraisal. Rheumatology 51(9):1540–1549CrossRefPubMed

53.

Rolla G, Fusaro E, Nicola S, Bucca C, Peroni C, Parisi S, Cassinis MC, Ferraris A, Angelino F, Heffler E, Boita M, Brussino L (2016) Th-17 cytokines and interstitial lung involvement in systemic sclerosis. J Breath Res 10(4):046013CrossRefPubMed

54.

Schmid AS, Hemmerle T, Pretto F, Kipar A, Neri D (2018) Antibody-based targeted delivery of interleukin-4 synergizes with dexamethasone for the reduction of inflammation in arthritis. Rheumatology 57(4):748–755CrossRefPubMed

55.

Bautista-Herrera LA, De la Cruz-Mosso U, Morales-Zambrano R et al (2018) Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables. Clin Exp Med 18(2):229–235CrossRefPubMed

56.

De la Cruz-Mosso U, Garcia-Iglesias T, Bucala R et al (2018) MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-alpha in PBMC from active SLE patients. Cell Immunol 324:42–49CrossRefPubMed

Titel: Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile
verfasst von: Christian Johana Baños-Hernández
José Eduardo Navarro-Zarza
Richard Bucala
Jorge Hernández-Bello
Isela Parra-Rojas
María Guadalupe Ramírez-Dueñas
Samuel García-Arellano
Luis Alexis Hernández-Palma
Andrea Carolina Machado-Sulbarán
José Francisco Muñoz-Valle
Publikationsdatum: 12.02.2019
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 6/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-019-04459-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile

Abstract

Introduction

Materials and methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study

Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases

MiR-5571-3p and miR-135b-5p, derived from analyses of microRNA profile sequencing, correlate with increased disease risk and activity of rheumatoid arthritis

Reply to the letter by Prof. Rothschild. DOI: 10.1007/s10067-019-04560-y

Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis

Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin